Interventional Cardiology & Surgery

heartwire News

Perspective

  • AHA HOPE-Duchenne and Help at Last The final day of AHA 2017 brought Dr Walton Shirley to tears with studies offering hope to ease the suffering she has witnessed firsthand.
  • AHA Trials We Did, Trials We Should Do Dr Walton-Shirley reflects on some major studies presented at AHA 2017 and offers a further way to approach each one.
  • Revascularization in CS: Keep It Simple and Get Out of Dodge   Drs Harrington, Batchelor, and O'Donoghue discuss the implications of the TCT late-breaking CULPRIT SHOCK trial testing culprit-only vs multivessel revascularization in unstable patients in cardiogenic shock.
  • TCT Seven Reasons New Data on Watchman Are Not Persuasive PREVAIL 5-year data and a patient-level meta-analysis nudge the Watchman left atrial appendage device to meeting noninferiority, but the devil is in the details, notes Dr Mandrola.